Article Details

iBio and Fraunhofer USA Conclude Litigation and Enter License Agreement

Retrieved on: 2021-05-04 21:00:00

Tags for this article:

Click the tags to see associated articles and topics

iBio and Fraunhofer USA Conclude Litigation and Enter License Agreement. View article details on hiswai:

Excerpt

... and novel glycosylation technologies to rapidly deliver high-quality monoclonal antibodies, vaccines, bioinks and other proteins. iBio is developing ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo